Cover Image
Market Research Report

Diabetic Retinopathy Market Size By Type, By Age Group, By Management, By Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

Published by Global Market Insights Inc. Product code 605740
Published Content info 120 Pages
Delivery time: 2-3 business days
Price
Back to Top
Diabetic Retinopathy Market Size By Type, By Age Group, By Management, By Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025
Published: April 18, 2019 Content info: 120 Pages
Description

Title:
Diabetic Retinopathy Market Size By Type (Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy), By Age Group (40-49, 50-64, 65-74), By Management (Anti-VEGF, Intraocular Steroid Injection, Laser Surgery, Vitrectomy), By Distribution Channel (Hospitals & Pharmacies, Eye Clinics, Ambulatory Surgical Centers (ASCs)), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, India, China, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Competitive Market Share & Forecast, 2019 - 2025.

Diabetic Retinopathy Market will exceed USD 12 billion by 2025; as per a new research report.

Rising prevalence of diabetes in developed as well as developing economies will positively influence the industry growth. According to WHO, people diagnosed with diabetes increased to 422 million in 2014. Diabetes has associated complications and most frequent amongst them is diabetic retinopathy. As per Hindawi Journal of Ophthalmology, 80% patients suffering from diabetes for more than 20 years have the tendency to acquire diabetic retinopathy. This scenario favors diabetic retinopathy market growth as it increases the demand for medications and ophthalmic surgical procedures.

Improvements in medications available for diabetic retinopathy treatment will foster the industry growth. Recently developed direct injections, intravitreal antiangiogenesis and anti-inflammatory agents are prominently used to treat diabetic retinopathy that has helped in retaining vision. Therefore, advances in medications and procedures have revolutionized the treatment for diabetic retinopathy thereby, escalating the industry growth. However, certain surgical procedures available for treatment of diabetic retinopathy may lead to post-surgical complications that may restrain the industry growth to some extent.

Proliferative diabetic retinopathy segment is predicted to witness 7.5% growth throughout the forecast time period. This type of condition is highly severe as it is most advanced phase of diabetic eye diseases and surgical procedures are crucial for improving vision. According to data of Apollo Hospitals, people above 60 years have the highest probability of acquiring proliferative diabetic retinopathy that should propel the segmental growth.

40-49 age group of diabetic retinopathy segment was valued around 3 billion in 2018. Vigorous segmental growth will be as a result of increasing prevalence of diabetic patients in this group. People in the age group of 40-49 consists of working professional that have unhealthy lifestyle such as lack of exercise and consumption of junk food that makes them susceptible to chronic diseases such as diabetes. According to NCBI article, patients suffering from diabetes have 30% probability of acquiring diabetic retinopathy. Thus, increasing prevalence of diabetes in age group of 40-49 should augment segmental growth.

Laser surgery segment will grow at 9.2% over the analysis period owing to shorter recovery period associated with it. Additionally, laser surgeries are minimally invasive, thus making the treatment less painful. Therefore, preference for minimally invasive surgeries is high in geriatric population that drives the segment growth. Furthermore, less post-surgical complications associated with laser surgery will positively influence the segment growth.

Ambulatory surgical centers (ASCs) segment was valued over 2 billion in 2018 and is expected to witness enormous growth over forecast timeframe. Diabetic retinopathy treatments are most probably performed on outpatient basis. Outpatient surgical procedure costs are comparatively less as the recovery period is short. Moreover, ophthalmic procedures performed at ASCs are reimbursed that increases its preference amongst people in developing economies facing affordability issues. Above mentioned factors are expected to drive the business growth.

North America diabetic retinopathy market was valued at USD 3 billion in 2018. Increasing geriatric population suffering from chronic conditions including diabetes will drive the regional industry growth. Elderly population base suffering from diabetes have the highest probability of acquiring diabetic retinopathy, that will lead to high demand for advanced medications in this region. Moreover, increasing awareness regarding availability of minimally invasive ophthalmic surgeries in North America has positively impacted the industry growth.

Prominent industry players operational in the diabetic retinopathy market include Regeneron Pharmaceuticals, BCN Peptides, Kowa Company, Allergan and Bayer AG, Novartis, Ampio Pharmaceuticals, ThromboGenics and Alimera Sciences. Key players adopt strategies such as mergers and acquisitions, emphasis on R&D and new product launch. Approval for product launch from regulatory bodies from FDA has positive impact on company's sales. For instance, in September 2014, Allergan announced approval of OZURDEX in the European Union for the treatment of Diabetic Macular Edema. Receiving FDA approval for newly developed products will boost company's growth.

Table of Contents
Product Code: 486

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Diabetic retinopathy industry 360 degree synopsis, 2014 - 2025
    • 2.1.1. Business trends
    • 2.1.2. Type trends
    • 2.1.3. Age group trends
    • 2.1.4. Management trends
    • 2.1.5. Distribution channel trends
    • 2.1.6. Regional trends

Chapter 3. Diabetic Retinopathy Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2014 - 2025
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Increasing technological advancements in diabetic retinopathy surgical instruments in developed countries
      • 3.3.1.2. Favorable reimbursement available for ophthalmologic surgeries in developed as well as developing economies
      • 3.3.1.3. Rising prevalence of diabetes in Asia Pacific and other underdeveloped economies
      • 3.3.1.4. Growing geriatric population in North America and Europe
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. Post-surgical complications
  • 3.4. Growth potential analysis
    • 3.4.1. By type
    • 3.4.2. By management
    • 3.4.3. By age group
    • 3.4.4. By distribution channel
  • 3.5. Porter's analysis
  • 3.6. Competitive landscape, 2017
    • 3.6.1. Strategy dashboard
  • 3.7. PESTEL analysis

Chapter 4. Diabetic Retinopathy Market, By Type

  • 4.1. Key segment trends
  • 4.2. Proliferative diabetic retinopathy
    • 4.2.1. Market size, by region, 2014-2025 (USD Million)
  • 4.3. Non-proliferative retinopathy
    • 4.3.1. Market size, by region, 2014-2025 (USD Million)

Chapter 5. Diabetic Retinopathy Market, By Age Group

  • 5.1. Key segment trends
  • 5.2. 40-49
    • 5.2.1. Market size, by region, 2014-2025 (USD Million)
  • 5.3. 50-64
    • 5.3.1. Market size, by region, 2014-2025 (USD Million)
  • 5.4. 65-74
    • 5.4.1. Market size, by region, 2014-2025 (USD Million)
  • 5.5. Others
    • 5.5.1. Market size, by region, 2014-2025 (USD Million)

Chapter 6. Diabetic Retinopathy Market, By Management

  • 6.1. Key segment trends
  • 6.2. Anti-VEGF
    • 6.2.1. Market size, by region, 2014-2025 (USD Million)
  • 6.3. Intraocular Steroid Injection
    • 6.3.1. Market size, by region, 2014-2025 (USD Million)
  • 6.4. Laser Surgery
      • 6.4.1.1. Market size, by region, 2014-2025 (USD Million)
  • 6.5. Vitrectomy
      • 6.5.1.1. Market size, by region, 2014-2025 (USD Million)

Chapter 7. Diabetic Retinopathy Market, By Distribution Channel

  • 7.1. Key segment trends
  • 7.2. Hospitals and pharmacies
    • 7.2.1. Market size, by region, 2014-2025 (USD Million)
  • 7.3. Eye Clinics
    • 7.3.1. Market size, by region, 2014-2025 (USD Million)
  • 7.4. Ambulatory surgical centers (ASCs)
    • 7.4.1. Market size, by region, 2014-2025 (USD Million)

Chapter 8. Diabetic Retinopathy Market, By Region

  • 8.1. Key regional trends
  • 8.2. North America
    • 8.2.1. Market size, by country, 2014-2025 (USD Million)
    • 8.2.2. Market size, by type, 2014-2025 (USD Million)
    • 8.2.3. Market size, by management, 2014-2025 (USD Million)
    • 8.2.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.2.5. Market size, by age group, 2014-2025 (USD Million)
    • 8.2.6. U.S.
      • 8.2.6.1. Market size, by type, 2014-2025 (USD Million)
      • 8.2.6.2. Market size, by management, 2014-2025 (USD Million)
      • 8.2.6.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.2.6.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.2.7. Canada
      • 8.2.7.1. Market size, by type, 2014-2025 (USD Million)
      • 8.2.7.2. Market size, by management, 2014-2025 (USD Million)
      • 8.2.7.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.2.7.4. Market size, by distribution channel, 2014-2025 (USD Million)
  • 8.3. Europe
    • 8.3.1. Market size, by country, 2014-2025 (USD Million)
    • 8.3.2. Market size, by type, 2014-2025 (USD Million)
    • 8.3.3. Market size, by management, 2014-2025 (USD Million)
    • 8.3.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.3.5. Market size, by age group, 2014-2025 (USD Million)
    • 8.3.6. Germany
      • 8.3.6.1. Market size, by type, 2014-2025 (USD Million)
      • 8.3.6.2. Market size, by management, 2014-2025 (USD Million)
      • 8.3.6.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.3.6.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.3.7. UK
      • 8.3.7.1. Market size, by type, 2014-2025 (USD Million)
      • 8.3.7.2. Market size, by management, 2014-2025 (USD Million)
      • 8.3.7.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.3.7.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.3.8. France
      • 8.3.8.1. Market size, by type, 2014-2025 (USD Million)
      • 8.3.8.2. Market size, by management, 2014-2025 (USD Million)
      • 8.3.8.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.3.8.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.3.9. Italy
      • 8.3.9.1. Market size, by type, 2014-2025 (USD Million)
      • 8.3.9.2. Market size, by management, 2014-2025 (USD Million)
      • 8.3.9.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.3.9.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.3.10. Spain
      • 8.3.10.1. Market size, by type, 2014-2025 (USD Million)
      • 8.3.10.2. Market size, by management, 2014-2025 (USD Million)
      • 8.3.10.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.3.10.4. Market size, by distribution channel, 2014-2025 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Market size, by country, 2014-2025 (USD Million)
    • 8.4.2. Market size, by type, 2014-2025 (USD Million)
    • 8.4.3. Market size, by management, 2014-2025 (USD Million)
    • 8.4.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.4.5. Market size, by age group, 2014-2025 (USD Million)
    • 8.4.6. China
      • 8.4.6.1. Market size, by type, 2014-2025 (USD Million)
      • 8.4.6.2. Market size, by management, 2014-2025 (USD Million)
      • 8.4.6.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.4.6.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.4.7. India
      • 8.4.7.1. Market size, by type, 2014-2025 (USD Million)
      • 8.4.7.2. Market size, by management, 2014-2025 (USD Million)
      • 8.4.7.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.4.7.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.4.8. Japan
      • 8.4.8.1. Market size, by type, 2014-2025 (USD Million)
      • 8.4.8.2. Market size, by management, 2014-2025 (USD Million)
      • 8.4.8.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.4.8.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.4.9. Australia
      • 8.4.9.1. Market size, by type, 2014-2025 (USD Million)
      • 8.4.9.2. Market size, by management, 2014-2025 (USD Million)
      • 8.4.9.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.4.9.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.4.10. South Korea
      • 8.4.10.1. Market size, by type, 2014-2025 (USD Million)
      • 8.4.10.2. Market size, by management, 2014-2025 (USD Million)
      • 8.4.10.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.4.10.4. Market size, by distribution channel, 2014-2025 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Market size, by country, 2014-2025 (USD Million)
    • 8.5.2. Market size, by type, 2014-2025 (USD Million)
    • 8.5.3. Market size, by management, 2014-2025 (USD Million)
    • 8.5.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.5.5. Market size, by age group, 2014-2025 (USD Million)
    • 8.5.6. Brazil
      • 8.5.6.1. Market size, by type, 2014-2025 (USD Million)
      • 8.5.6.2. Market size, by management, 2014-2025 (USD Million)
      • 8.5.6.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.5.6.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.5.7. Mexico
      • 8.5.7.1. Market size, by type, 2014-2025 (USD Million)
      • 8.5.7.2. Market size, by management, 2014-2025 (USD Million)
      • 8.5.7.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.5.7.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.5.8. Argentina
      • 8.5.8.1. Market size, by type, 2014-2025 (USD Million)
      • 8.5.8.2. Market size, by management, 2014-2025 (USD Million)
      • 8.5.8.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.5.8.4. Market size, by distribution channel, 2014-2025 (USD Million)
  • 8.6. MEA
    • 8.6.1. Market size, by country, 2014-2025 (USD Million)
    • 8.6.2. Market size, by type, 2014-2025 (USD Million)
    • 8.6.3. Market size, by management, 2014-2025 (USD Million)
    • 8.6.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.6.5. Market size, by age group, 2014-2025 (USD Million)
    • 8.6.6. South Africa
      • 8.6.6.1. Market size, by type, 2014-2025 (USD Million)
      • 8.6.6.2. Market size, by management, 2014-2025 (USD Million)
      • 8.6.6.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.6.6.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.6.7. Saudi Arabia
      • 8.6.7.1. Market size, by type, 2014-2025 (USD Million)
      • 8.6.7.2. Market size, by management, 2014-2025 (USD Million)
      • 8.6.7.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.6.7.4. Market size, by distribution channel, 2014-2025 (USD Million)
    • 8.6.8. UAE
      • 8.6.8.1. Market size, by type, 2014-2025 (USD Million)
      • 8.6.8.2. Market size, by management, 2014-2025 (USD Million)
      • 8.6.8.3. Market size, by age group, 2014-2025 (USD Million)
      • 8.6.8.4. Market size, by distribution channel, 2014-2025 (USD Million)

Chapter 9. Company Profiles

  • 9.1. Bayer Healthcare
    • 9.1.1. Business overview
    • 9.1.2. Financial data
    • 9.1.3. Product landscape
    • 9.1.4. Strategic outlook
    • 9.1.5. SWOT analysis
  • 9.2. Novartis AG
    • 9.2.1. Business overview
    • 9.2.2. Financial data
    • 9.2.3. Product landscape
    • 9.2.4. Strategic outlook
    • 9.2.5. SWOT analysis
  • 9.3. Regeneron Pharmaceuticals Inc.
    • 9.3.1. Business overview
    • 9.3.2. Financial data
    • 9.3.3. Product landscape
    • 9.3.4. Strategic outlook
    • 9.3.5. SWOT analysis
  • 9.4. Allergan plc
    • 9.4.1. Business overview
    • 9.4.2. Financial data
    • 9.4.3. Product landscape
    • 9.4.4. Strategic outlook
    • 9.4.5. SWOT analysis
  • 9.5. ThromboGenics NV
    • 9.5.1. Business overview
    • 9.5.2. Financial data
    • 9.5.3. Product landscape
    • 9.5.4. Strategic outlook
    • 9.5.5. SWOT analysis
  • 9.6. Sirnaomics, Inc.
    • 9.6.1. Business overview
    • 9.6.2. Financial data
    • 9.6.3. Product landscape
    • 9.6.4. Strategic outlook
    • 9.6.5. SWOT analysis
  • 9.7. Genentech
    • 9.7.1. Business overview
    • 9.7.2. Financial data
    • 9.7.3. Product landscape
    • 9.7.4. Strategic outlook
    • 9.7.5. SWOT analysis
  • 9.8. Alimera Sciences
    • 9.8.1. Business overview
    • 9.8.2. Financial data
    • 9.8.3. Product landscape
    • 9.8.4. Strategic outlook
    • 9.8.5. SWOT analysis
  • 9.9. Ampio Pharmaceuticals
    • 9.9.1. Business overview
    • 9.9.2. Financial data
    • 9.9.3. Product landscape
    • 9.9.4. Strategic outlook
    • 9.9.5. SWOT analysis
  • 9.10. BCN Peptides
    • 9.10.1. Business overview
    • 9.10.2. Financial data
    • 9.10.3. Product landscape
    • 9.10.4. Strategic outlook
    • 9.10.5. SWOT analysis
  • 9.11. Kowa Group
    • 9.11.1. Business overview
    • 9.11.2. Financial data
    • 9.11.3. Product landscape
    • 9.11.4. Strategic outlook
    • 9.11.5. SWOT analysis

Data Tables

  • TABLE 1. Diabetic retinopathy industry 36 degree synopsis, 2014 - 2025
  • TABLE 2. Diabetic retinopathy Market size, 2014 - 2025 (USD Million)
  • TABLE 3. Diabetic retinopathy Market size, by type, 2014 - 2025 (USD Million)
  • TABLE 4. Diabetic retinopathy Market size, by management, 2014 - 2025 (USD Million)
  • TABLE 5. Diabetic retinopathy Market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 6. Diabetic retinopathy Market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 7. Industry impact forces
  • TABLE 8. Proliferative diabetic retinopathy market size, by region, 2014 - 2025 (USD Million)
  • TABLE 9. Non-proliferative diabetic retinopathy market size, by region, 2014 - 2025 (USD Million)
  • TABLE 10. 40-49 market size, by region, 2014 - 2025 (USD Million)
  • TABLE 11. 50-64 market size, by region, 2014 - 2025 (USD Million)
  • TABLE 12. 65-74 market size, by region, 2014 - 2025 (USD Million)
  • TABLE 13. Anti-VEGF market size, by region, 2014 - 2025 (USD Million)
  • TABLE 14. Intraocular steroid injection market size, by region, 2014 - 2025 (USD Million)
  • TABLE 15. Laser surgery market size, by region, 2014 - 2025 (USD Million)
  • TABLE 16. Vitrectomy market size, by region, 2014 - 2025 (USD Million)
  • TABLE 17. Hospitals and pharmacies market size, by region, 2014 - 2025 (USD Million)
  • TABLE 18. Eye clinics applications market size, by region, 2014 - 2025 (USD Million)
  • TABLE 19. Ambulatory surgical centers (ASCs) market size, by region, 2014 - 2025 (USD Million)
  • TABLE 20. North America diabetic retinopathy market size, by country, 2014 - 2025 (USD Million)
  • TABLE 21. North America diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 22. North America diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 23. North America diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 24. North America diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 25. U.S. diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 26. U.S. diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 27. U.S. diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 28. U.S. diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 29. Canada diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 30. Canada diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 31. Canada diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 32. Canada diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 33. Europe diabetic retinopathy market size, by country, 2014 - 2025 (USD Million)
  • TABLE 34. Europe diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 35. Europe diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 36. Europe diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 37. Europe diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 38. Germany diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 39. Germany diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 40. Germany diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 41. Germany diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 42. UK diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 43. UK diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 44. UK diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 45. UK diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 46. France diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 47. France diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 48. France diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 49. France diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 50. Italy diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 51. Italy diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 52. Italy diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 53. Italy diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 54. Spain diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 55. Spain diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 56. Spain diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 57. Spain diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 58. Asia Pacific diabetic retinopathy market size, by country, 2014 - 2025 (USD Million)
  • TABLE 59. Asia Pacific diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 60. Asia Pacific diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 61. Asia Pacific diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 62. Asia Pacific diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 63. China diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 64. China diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 65. China diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 66. China diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 67. India diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 68. India diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 69. India diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 70. India diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 71. Japan diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 72. Japan diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 73. Japan diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 74. Japan diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 75. Australia diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 76. Australia diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 77. Australia diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 78. Australia diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 79. South Korea diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 80. South Korea diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 81. South Korea diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 82. South Korea diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 83. Latin America diabetic retinopathy market size, by country, 2014 - 2025 (USD Million)
  • TABLE 84. Latin America diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 85. Latin America diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 86. Latin America diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 87. Latin America diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 88. Brazil diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 89. Brazil diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 90. Brazil diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 91. Brazil diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 92. Mexico diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 93. Mexico diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 94. Mexico diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 95. Mexico diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 96. Argentina diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 97. Argentina diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 98. Argentina diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 99. Argentina diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 100. MEA diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 101. MEA diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 102. MEA diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 103. MEA diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 104. South Africa diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 105. South Africa diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 106. South Africa diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 107. South Africa diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 108. Saudi Arabia diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 109. Saudi Arabia diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 110. Saudi Arabia diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 111. Saudi Arabia diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)
  • TABLE 112. UAE diabetic retinopathy market size, by type, 2014 - 2025 (USD Million)
  • TABLE 113. UAE diabetic retinopathy market size, by management, 2014 - 2025 (USD Million)
  • TABLE 114. UAE diabetic retinopathy market size, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 115. UAE diabetic retinopathy market size, by age group, 2014 - 2025 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Diabetic retinopathy market size, 2014 - 2025 (USD Million)
  • FIG. 3 Growth potential analysis, by type
  • FIG. 4 Growth potential analysis, by management
  • FIG. 5 Growth potential analysis, by age group
  • FIG. 6 Growth potential analysis, by distribution channel
  • FIG. 7 Porter's analysis
  • FIG. 8 Strategy dashboard, 2017
  • FIG. 9 PESTEL analysis
Back to Top